CONCORD BIOTECH LIMITED (CONCORDBIO)

NSE: ₹1,238.20
BSE: ₹1,237.80
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Revenue from Operations 262.35 240.80 318.97 215.80 310.18 244.22 429.88 203.99 247.06 277.77 326.08 257.49
YOY Revenue Growth % - - - 10.77% 18.23% 1.42% 34.77% -5.47% -20.35% 13.74% -24.15% 26.23%
Other Income 8.13 8.19 10.81 10.31 10.03 14.73 9.38 13.68 13.35 9.98 15.35 12.83
Total Income 270.47 248.98 329.78 226.11 320.21 258.95 439.27 217.67 260.41 287.74 341.43 270.31
Total Expenses + 157.29 148.90 198.86 147.94 186.91 159.63 254.17 160.43 177.02 197.61 227.18 193.25
Cost of Materials Consumed 42.00 47.39 55.67 55.03 68.05 60.96 80.27 59.91 57.30 66.59 70.54 69.85
Employee Benefit Expense 30.17 30.67 33.96 31.66 33.66 34.64 38.97 37.90 44.46 46.78 47.77 43.64
Other Expenses 60.12 57.11 61.88 54.56 63.52 59.23 72.00 59.59 65.09 66.27 73.96 77.18
Operating Profit 105.05 91.90 120.11 67.86 123.27 84.59 175.71 43.56 70.04 80.15 98.90 64.24
OPM % 40% 38.2% 37.7% 31.4% 39.7% 34.6% 40.9% 21.4% 28.3% 28.9% 30.3% 24.9%
Profit Before Tax + 113.18 100.08 130.92 78.17 133.29 99.32 185.09 57.24 83.39 86.85 114.25 77.07
Tax Expense 32.16 22.51 35.90 18.57 37.55 23.40 44.71 13.18 20.33 23.21 25.79 19.37
Tax % 28.4% 22.5% 27.4% 23.8% 28.2% 23.6% 24.2% 23% 24.4% 26.7% 22.6% 25.1%
Profit After Tax 81.02 77.57 95.02 59.59 95.74 75.92 140.39 44.06 63.06 63.64 88.47 57.70
EPS (Basic) 7.74 7.41 9.08 5.70 9.15 7.26 13.42 4.21 6.03 6.08 8.46 5.52

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024
Revenue from Operations 1,054.89 1,200.09 1,016.94
YOY Revenue Growth % -12.1% 18.01% -
Other Income 52.36 44.45 33.78
Total Income 1,107.25 1,244.53 1,050.72
Total Expenses + 762.23 748.66 641.53
Cost of Materials Consumed 254.35 264.31 184.54
Employee Benefit Expense 176.90 138.93 123.05
Other Expenses 264.91 249.31 233.14
Operating Profit 292.66 451.43 375.41
OPM % 27.7% 37.6% 36.9%
Profit Before Exceptional 345.01 495.88 409.19
Exceptional Items -3.28 0.00 0.00
Profit Before Tax + 341.74 495.88 409.19
Tax Expense 82.51 124.23 101.09
Tax % 24.1% 25.1% 24.7%
Profit After Tax 259.23 371.64 308.10
EPS (Basic) 24.78 35.52 29.45

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024
ASSETS
Non-Current Assets + 984.62 899.01 804.48
Property, Plant & Equipment 785.72 791.81 571.73
Capital Work in Progress 78.16 50.13 211.48
Non-Current Investments 84.94 17.99 0.00
Goodwill 0.40 0.00 0.00
Other Intangible Assets 2.44 2.28 3.58
Current Assets + 1,250.11 1,135.24 896.23
Inventories 326.36 239.67 207.95
Trade Receivables 460.20 521.65 349.61
Cash and Cash Equivalents 12.19 0.90 15.14
Current Investments 402.06 316.54 243.70
LIABILITIES & EQUITY
Total Equity 2,015.14 1,812.72 1,526.65
Equity Share Capital 10.46 10.46 10.46
Other Equity 2,006.60 1,802.26 1,516.18
Non-Current Liabilities 50.51 37.47 31.91
Current Liabilities 169.08 184.06 142.16
Total Liabilities 219.59 221.53 174.06

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024
Cash from Operating Activities 266.88 244.52 265.47
Cash from Investing Activities -142.72 -159.99 -154.61
Cash from Financing Activities -112.88 -98.77 -99.21
Net Increase/Decrease in Cash 11.28 -14.24 11.64